Top-Rated Charity
View similar charities
Ratings & Metrics
Financial Documents
| Entity | Document Type | Tax ID |
|---|---|---|
| National Hemophilia Foundation | Audited Financial Statements | 13-5641857 |
| National Hemophilia Foundation | IRS Form 990 | 13-5641857 |
|
Entity: National Hemophilia Foundation Document Type: Audited Financial Statements Tax ID: 13-5641857 |
|
Entity: National Hemophilia Foundation Document Type: IRS Form 990 Tax ID: 13-5641857 |
Governance & Transparency
CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
Top Salaries
| Name | Title | Compensation | |
|---|---|---|---|
| 1 | Val Bias | CEO | $413,482 |
| 2 | Jordana Zeger | COO | $278,142 |
| 3 | Michelle Rice | Senior VP, Public Policy & Stakeholder Relations | $220,302 |
|
1 Name: Val Bias Title: CEO Compensation: $413,482 |
|
2 Name: Jordana Zeger Title: COO Compensation: $278,142 |
|
3 Name: Michelle Rice Title: Senior VP, Public Policy & Stakeholder Relations Compensation: $220,302 |
Analysts' Notes
CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.
| According to the National Hemophilia Foundation (NHF) audit of December 31, 2017 (Note 1): "The Foundation and other independent organizations ('member chapters') actively collaborate in furthering the Foundation's mission throughout the United States. These [audited] financial statements represent only the financial position and activities of the National Hemophilia Foundation and do not include the accounts of the 'member chapters'. On June 23, 2011, five chapters merged with NHF. On February 24, 2014, a sixth chapter and on January 27, 2016 a seventh chapter was created by the Foundation; consequently, the two newly created chapters along with those of the five previously merged chapters are included in the financial statements of NHF. All other member chapters continue to operate independently of NHF and thus, are not included in the financial statements of NHF." The five chapters that merged with NHF in 2011 are the Central Ohio, Idaho, Nevada, Colorado, and Nebraska chapters. The sixth and seventh chapters that were created in 2014 and 2016 are the West Virginia and Hawaii chapter, respectively. Given that the financial activities of these seven chapters are included in NHF's audited financial statements, they also are included in CharityWatch's rating of National Hemophilia Foundation (National Office). Our rating does not include the other, independently operated chapters of NHF. |
| According to the National Hemophilia Foundation audit of December 31, 2017 (Note 1): "... For the years ended December 31, 2017 and 2016, approximately 37% of the Foundation's total support and revenue were provided by two pharmaceutical companies..." |
| According to the National Hemophilia Foundation (NHF) 2017 tax filing, NHF reports re: Compensation, Supplemental Information (IRS Form 990, Schedule J, Part III): Regarding nonfixed payments to officers, directors, trustees, key employees and highest compensated employees (Schedule J, Part I, Line 7): "The CEO shall be eligible to receive an annual bonus of up to 10% of base salary based on performance in a contract year. The form and amount of any performance bonus shall be within the board's discretion. The bonus determination will be made pursuant to a formalized review process conducted by the board of directors." [NHF reports $0 under "Bonus & incentive compensation" for the CEO in 2017 (IRS Form 990, Schedule J, Part II).] |